Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through phosphatidylinositol 3-kinase/protein kinase B signal pathway

刘剑毅; 李世荣

您当前的位置：

首页 >

文章列表页 >

Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through phosphatidylinositol 3-kinase/protein kinase B signal pathway

更新时间：2026-01-09

- Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through phosphatidylinositol 3-kinase/protein kinase B signal pathway
- Journal of Army Medical University Vol. 30, Issue 10, Pages: 921-923(2008)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R329.28;R341;R619.6
- Published：2008
- 稿件说明：
移动端阅览
刘剑毅,李世荣.结缔组织生长因子通过PI3K/PKB抑制人增生性瘢痕成纤维细胞凋亡[J].陆军军医大学学报(原第三军医大学学报),2008,30(10):921-923.

　LIU Jian-yi,LI Shi-rong.Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through phosphatidylinositol 3-kinase/protein kinase B signal pathway[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(10):921-923.
刘剑毅,李世荣.结缔组织生长因子通过PI3K/PKB抑制人增生性瘢痕成纤维细胞凋亡[J].陆军军医大学学报(原第三军医大学学报),2008,30(10):921-923. DOI：

　LIU Jian-yi,LI Shi-rong.Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through phosphatidylinositol 3-kinase/protein kinase B signal pathway[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(10):921-923. DOI：

摘要

目的探讨结缔组织生长因子（connective tissue growth factor，CTGF）是否具有抑制人增生性瘢痕成纤维细胞（hypertrophic scar fibroblast，HSF）凋亡的作用及磷脂酰肌醇3激酶/蛋白激酶B信号通路(PI3K/PKB)是否介导该效应。方法体外培养HSF，实验分3组：①空白对照组，②CTGF刺激组（10 ng/ml），③PI3K抑制剂LY294002（10 μmol/L）预处理后CTGF刺激组(LY294002组)。应用免疫印迹技术检测30 min后蛋白激酶B的活化情况，应用流式细胞术检测细胞凋亡。结果和空白对照组相比，CTGF组细胞凋亡指数下降，蛋白激酶B的活化水平升高，具有统计学差异（P0.05）；LY294002组细胞凋亡指数上升，蛋白激酶B的活化水平没有升高，与CTGF组比较具有显著性差异（P0.05）。结论 CTGF能够抑制HSF凋亡，PI3K/PKB介导该效应。

Abstract

Objective To explore whether the anti-apoptotic effect of connective tissue growth factor on human hypertrophic scar fibroblasts is mediated by phosphatidylinositol 3-kinase/protein kinase B (PI3K/PKB) signal pathway. Methods The cultured human hypertrophic scar fibroblasts were divided into three groups: control group

connective tissue growth factor (10 ng/ml) stimulated group

the group pretreated with PI3K inhibitor LY294002 (10 μmol/L) and stimulated with connective tissue growth factor. Levels of phosphorylated PKB were examined by Western blotting in human hypertrophic scar fibroblasts that were stimulated with connective tissue growth factor for 30 min. Flow cytometry was used to detect the apoptosis ratio of the cells. Results Compared with the control group

the apoptosis ratio of the connective tissue growth factor stimulated group decreased (P0.05) and the activation of PKB increased (P0.05). However

the apoptosis ratio of connective tissue growth factor stimulated group after the pretreatment of PI3K inhibitor LY294002 increased (P0.05)

and the activation of PKB remained as the control group. Conclusion It is proven that connective tissue growth factor can inhibit the apoptosis of human hypertrophic scar fibroblasts through PI3K/PKB signaling pathway.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expression of miR-616 in osteosarcoma and its role in proliferation, apoptosis, migration and invasion of tumor cells

Regulation and mechanism of Gm49394 on islet-β cell apoptosis

Celastrol exerts anti-ER+ breast cancer by activating endoplasmic reticulum stress to induce apoptosis

Establishment of rat model of sarcopenia by ovariectomy and estrogen replacement therapy

Inhibition of lysyl oxidase accelerates intervertebral disc degeneration induced by apoptosis of nucleus pulposus cells

Related Author

FU Wanlei

HAO Xianglin

CAO Ya

XIA Jiying

ZHOU Xiaogang

XU Jiayi

GUO Qiaonan

LIU Dong

Related Institution

Department of Pathology， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Immunology, Faculty of Pharmacy and Laboratory Medicine， Army Medical University （Third Military Medical University）

Department of Laboratory Animal Science， College of Basic Medical Sciences, Faculty of Pharmacy and Laboratory Medicine， Army Medical University （Third Military Medical University）

Department of Pharmaceutical Analysis, Faculty of Pharmacy and Laboratory Medicine， Army Medical University （Third Military Medical University）

Department of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, Third Military Medical University

⁰